226 related articles for article (PubMed ID: 21897920)
1. Mesoporous silica functionalized with an AIE luminogen for drug delivery.
Li D; Yu J; Xu R
Chem Commun (Camb); 2011 Oct; 47(39):11077-9. PubMed ID: 21897920
[TBL] [Abstract][Full Text] [Related]
2. AIE luminogen bridged hollow hydroxyapatite nanocapsules for drug delivery.
Li D; Liang Z; Chen J; Yu J; Xu R
Dalton Trans; 2013 Jul; 42(27):9877-83. PubMed ID: 23689833
[TBL] [Abstract][Full Text] [Related]
3. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
5. Luminescent porous silica fibers as drug carriers.
Hou Z; Zhang C; Li C; Xu Z; Cheng Z; Li G; Wang W; Peng C; Lin J
Chemistry; 2010 Dec; 16(48):14513-9. PubMed ID: 21077051
[TBL] [Abstract][Full Text] [Related]
6. AIE Luminogen-Functionalized Hollow Mesoporous Silica Nanospheres for Drug Delivery and Cell Imaging.
Fan Z; Li D; Yu X; Zhang Y; Cai Y; Jin J; Yu J
Chemistry; 2016 Mar; 22(11):3681-5. PubMed ID: 26711307
[TBL] [Abstract][Full Text] [Related]
7. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
9. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
10. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
11. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
12. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
Zhu S; Zhou Z; Zhang D
Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
[TBL] [Abstract][Full Text] [Related]
13. Regulation role of ibuprofen toward the morphology of porous silica nanospheres during its in situ encapsulation.
Du X; He J
J Colloid Interface Sci; 2010 May; 345(2):269-77. PubMed ID: 20219205
[TBL] [Abstract][Full Text] [Related]
14. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
15. Facile large-scale preparation of mesoporous silica microspheres with the assistance of sucrose and their drug loading and releasing properties.
Bi Y; Wu C; Xin M; Bi S; Yan C; Hao J; Li F; Li S
Int J Pharm; 2016 Mar; 500(1-2):77-84. PubMed ID: 26784977
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
[TBL] [Abstract][Full Text] [Related]
17. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
[TBL] [Abstract][Full Text] [Related]
20. [Structure and adsorption characterization of SBA-16 and functionalized materials].
Zheng Z; Guo G; Hu Y; Feng F; Xu G; Tan H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):768-73. PubMed ID: 21936378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]